Patents for A61P 23 - Anaesthetics (4,141)
11/2004
11/10/2004EP1474398A1 N-allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use of the same as pharmaceuticals
11/10/2004EP1474150A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones
11/10/2004EP1246793B1 Substituted aminomethyl-phenyl-cyclohexane derivatives
11/09/2004US6815555 Substituted phenol compounds useful for anesthesia and sedation
11/09/2004CA2260750C Methods for providing safe local anesthesia
11/04/2004US20040220077 Therapy for neuropathic pain
11/04/2004US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/03/2004EP1473032A1 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia
11/03/2004EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004CN1543342A Controlled heat induced rapid delivery of pharmaceuticals from skin depot
11/02/2004US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression
11/02/2004CA2338704C Oral liquid mucoadhesive compositions
10/2004
10/30/2004CA2431742A1 Formulations for anaesthetic use
10/28/2004WO2004092187A1 Phosphate derivatives
10/28/2004WO2004092186A1 Phosphates of secondary alcohols
10/28/2004WO2004091636A1 Phosphate derivatives of pharmaceutical products
10/28/2004WO2004091589A1 Transdermally administerable tranquilizing and sedating agent
10/28/2004WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity
10/28/2004CA2521842A1 Phosphate derivatives of pharmaceutical products
10/28/2004CA2521837A1 Phosphate derivatives
10/28/2004CA2521836A1 Phosphates of secondary alcohols
10/27/2004EP1469886A2 Pharmaceutical composition
10/27/2004EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives
10/27/2004CN1172913C Levobubikain carbnoate and its preparation
10/21/2004WO2004089912A1 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
10/21/2004US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid.
10/20/2004EP1468679A2 Controlled release formulation containing tramadol
10/20/2004EP1351669B1 Clear propofol compositions
10/20/2004CN1171883C Nonsteroidal antiinflammatories
10/19/2004US6806251 Method of treating pain
10/14/2004WO2004087938A1 Novel physiologically active substances pf1270a, b and c
10/13/2004EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same
10/13/2004CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004CN1537004A Compositions containing imidazotriazinone for nasal application
10/07/2004US20040198816 Administering mixture of anesthetic and adrenergic receptor antagonist; reverse with low dosage of adrenergic receptor antagonist; used for hair grafting
10/06/2004EP1463486A2 Anaesthetic compositions and method for their administration
10/05/2004CA2338480C Oral liquid mucoadhesive compositions
09/2004
09/30/2004WO2004082585A2 Water-soluble conjugates of phenytoin
09/30/2004WO2004064912A8 An otorhinological delivery device
09/30/2004WO2004052337A3 Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient
09/30/2004WO2003068197A8 Method for systemic drug delivery through the nail
09/30/2004US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating
09/30/2004US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
09/30/2004US20040192886 for use in the treatment and prevention of nervous system, epileptic, pain and vision defects; neuromuscular blocking agents; local anesthetic ; analgesics; neuroprotective agents
09/30/2004US20040192691 Analgesics; antiischemic agents; amyotrophic lateral sclerosis; anticonvulsants; antidepressants; local anesthetics; antiarrhythmia agents; neuropathic pain
09/29/2004EP1461122A2 Treatment of genitourinary tract disorders
09/29/2004CN1533374A Substitutled cyclohexane-1,4-diamine derivatives
09/23/2004US20040186104 Novel pyridinone and related heterocyclic derivatives
09/23/2004US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/23/2004US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma
09/22/2004EP1458355A2 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
09/22/2004EP1274709B1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
09/22/2004CN1167686C Novel benzimidazole derivatives and pharmaceutical compsns. comprising these compounds
09/21/2004US6794166 Identification and molecular characterization of proteins, expressed in the Ixodes ricinus salivary glands
09/15/2004EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof
09/15/2004EP1455830A1 Selective anesthetic agents and methods of identifying the same
09/14/2004US6790855 Two compounds, one effecting opioid analgesia and one effecting local anesthesia, in amounts sufficient to potentiate an antinociceptive response when both compounds are topically administered
09/09/2004US20040176364 Aryl substituted thiazinidinones and the use thereof
09/09/2004DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible
09/08/2004EP1453483A2 High-concentration lidocaine compositions and methods for their preparation
09/08/2004EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
09/02/2004WO2004074275A1 Indazolamides with analgesic activity
09/02/2004US20040171677 for combatting neuropathic pain.for the treatment of neurodegenerative diseases, preferably of Alzheimer's disease, Parkinson's disease or Huntington's chorea, migraine, stroke, cerebral ischaemia, cerebral infarct, cerebral edema, schizophrenia
09/01/2004EP1450783A1 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
09/01/2004EP1242410B1 Novel compounds
08/2004
08/25/2004EP1449846A1 3-alpha Hydroxy-3-beta methoxymethyl-21-heterocycle substituted steriods with anaesthetic activity
08/25/2004EP1448192A2 Novel methods of treating local fungal and bacterial infections
08/19/2004US20040162287 Substituted cyclohexane-1,4-diamine compounds
08/18/2004EP1446103A2 Injectable compositions for the controlled delivery of pharmacologically active compound
08/12/2004WO2003037863A3 Substituted indoles, method for production and use thereof for the inhibition of pain
08/12/2004US20040157823 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
08/12/2004US20040156891 gradient loading procedure, at a pH that prevents precipitation of the drug from the loading solution; preparing giant multivesicular liposomes with high drug-to-lipid ratios; provide long term analgesia.
08/11/2004EP1444212A1 Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- and 4-heteroarylcyclohexane compounds
08/11/2004EP1444206A1 Substituted benzo b azepin-2-one compounds
08/11/2004EP1443986A2 Drug delivery system for conscious sedation
08/11/2004CN1161087C Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals
08/05/2004WO2004064912A1 An otorhinological delivery device
08/05/2004US20040152734 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds
08/05/2004US20040152731 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivaties and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/04/2004EP1442745A1 Orally administrable opioid formulations having extended duration of effect
08/04/2004EP1441635A2 Sterile, breathable patch for treating wound pain
08/04/2004EP1150658B1 Method for controlling liposome size
08/03/2004US6770661 Aryl substituted pyridines and their use
07/2004
07/29/2004WO2004047819A3 Composition and its use for treating neuropathic sensory loss
07/29/2004US20040147741 Heptadecapeptide nociceptin opioid receptor modulators; pain relievers; synthesis
07/29/2004US20040147607 Storage stability
07/28/2004CN1516692A Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents
07/28/2004CN1516586A Novel oral general anesthetics and metabolitically resistant anticonvulsants
07/22/2004WO2004041269A3 New use for pharmaceutical composition
07/22/2004US20040142944 Compositions for nasal application
07/22/2004US20040142022 exposure to electron beam radiation, preferably low level electron beam radiation, to produce sterilized patch for transdermal delivery
07/21/2004EP1438942A1 An otorhinological drug delivery device
07/21/2004EP1438020A2 Topical compositions and methods for treating pain
07/21/2004EP1437961A2 Methods of suppressing microglial activation
07/21/2004CN1514719A Method of forming aerosol for inhalation delivery
07/20/2004US6764678 Local anesthetic methods and kits
07/15/2004US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries
07/15/2004US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 42